Skip to main content
Journal of Bacteriology logoLink to Journal of Bacteriology
. 2015 Jul 6;197(15):2593–2599. doi: 10.1128/JB.00188-15

Phase-Variable Control of Multiple Phenotypes in Acinetobacter baumannii Strain AB5075

Kyle A Tipton a, Daniela Dimitrova a, Philip N Rather a,b,✉
Editor: P de Boer
PMCID: PMC4518826  PMID: 26013481

ABSTRACT

Acinetobacter baumannii strain AB5075 produces colonies with two opacity phenotypes, designated opaque and translucent. These phenotypes were unstable and opaque and translucent colony variants were observed to interconvert at high frequency, suggesting that a phase-variable mechanism was responsible. The frequency of phase variation both within colonies and in broth cultures increased in a cell density-dependent manner and was mediated by the accumulation of an extracellular factor. This factor was distinct from the known A. baumannii signaling molecule 3-OH C12-homoserine lactone. Opaque and translucent colony variants exhibited a number of phenotypic differences, including cell morphology, surface motility, biofilm formation, antibiotic resistance, and virulence in a Galleria mellonella model. Additional clinical isolates exhibited a similar phase-variable control of colony opacity, suggesting that this may be a common feature of A. baumannii.

IMPORTANCE A novel phase-variable mechanism has been identified in Acinetobacter baumannii that results in an interconversion between opaque and translucent colony phenotypes. This phase variation also coordinately regulates motility, cell shape, biofilm formation, antibiotic resistance, and virulence. The frequency of phase variation is increased at high cell density via a diffusible extracellular signal. To our knowledge, this report presents the first example of phase variation in A. baumannii and also the first example of quorum sensing-mediated control of phase variation in a bacterium. The findings are important, as this phase-variable mechanism can be identified only via changes in colony opacity using oblique light; therefore, many researchers studying A. baumannii may unknowingly be working with different colony variants.

INTRODUCTION

Acinetobacter baumannii is a Gram-negative bacterium and a member of the Acinetobacter baumannii-calcoaceticus complex (1). These bacteria are primarily associated with infections in hospital settings or in patients that are immunocompromised or severely injured (2–9). The ability to treat infections due to members of the Acinetobacter baumannii-calcoaceticus complex has been complicated by extensive resistance to multiple classes of antibiotics (10–15). Colistin and the carbapenems often remain the antibiotics of last choice, and the frequency of multidrug-resistant strains with no therapeutic options has risen in recent years (11–15).

Surface properties of a bacterium, such as capsule production, outer membrane proteins, and surface carbohydrates, are often regulated by a process termed phase variation (16, 17). A prominent phenotype resulting from these surface changes is differences in colony opacity, and some examples of this are seen in Vibrio parahaemolyticus, Streptococcus pneumoniae, and Neisseria gonorrhoeae (18–22). Phase variation results from a high-frequency switch that confers on and off states for a given gene. Typically these changes occur in 1/1,000 cells and are often reversible at the same frequency (16). Mechanisms that contribute to phase variation include slipped-strand mispairing at regions of consecutive nucleotides or nucleotide repeats, DNA inversions mediated by site-specific recombinases, RecA-mediated rearrangements at repeated sequences, and altered methylation of regulatory regions (16, 20–25).

In this report, we present a phase-variable-like mechanism that generates opaque and translucent colony variants in A. baumannii. The opaque and translucent variants exhibited significant phenotypic differences, which included cell morphology, surface motility, biofilm formation, antibiotic resistance, and virulence in a Galleria mellonella waxworm model. This phase variation was shown to be increased in a density-dependent manner by the accumulation of an extracellular signal. Finally, we demonstrate that this phase-variable switching is exhibited by additional clinical isolates of A. baumannii. Overall, the findings reported here have important implications, as these colony opacity differences and the resulting phenotypic differences cannot be detected under normal lighting conditions. Therefore, researchers may be unknowingly working with different colony variants of the same strain, which can have important implications for a variety of studies, especially those involving virulence.

MATERIALS AND METHODS

Strains and growth conditions.

A. baumannii strain AB5075 (26) and an isogenic abaI::Tc mutant were obtained from Colin Manoil at the University of Washington. Strains ATCC 17978, AB1712, and AB0057 (27, 28) were obtained from Robert Bonomo at Case Western Reserve University. Strain AB307 was obtained from Anthony Campagnari at the University of Buffalo. Fresh clinical isolates of A. baumannii were obtained from Sarah Satola at the Emory University School of Medicine. These isolates included AB732, AB248, AB45, AB991, AB997, AB1009, AB1011, AB1013, AB1020, AB499, AB552, AB1040, AB1051, AB1056, and AB1062. Growth conditions consisted of modified LB containing 10 g of tryptone, 5 g of yeast extract, and 5 g of NaCl per liter. Agar was added to 1.5% or 0.8% as indicated below. Motility assays were conducted on LB plates containing 0.3% Eiken agar. For all experiments involving opaque and translucent variants, a freezer stock of each was used that contained less than 0.5% of the other colony type.

For the growth of strains in this study, the optical densities represent the non-dilution-adjusted values when readings were above 1.0. The dilution-adjusted densities for cells at an A600 of 1.1 corresponded to 1.8 when diluted. For an optical density of 1.3, cells corresponded to an optical density of 2.5 when diluted and for cells at an optical density of 1.7, cells corresponded to an optical density of 4.0 when diluted.

Conditioned medium was prepared from A. baumannii or Escherichia coli by growing cells in 25 ml of LB to an A600 of 1.7. Cells were then pelleted by centrifugation, and the resulting supernatant was adjusted to pH 6.5 with HCl and filter sterilized using a 0.22-μm filter unit attached to a syringe. The cell-free spent medium was immediately frozen at −80°C and used within 2 weeks. To add back nutrients, a 10× concentrate of tryptone and yeast extract was added back to a final concentration of 0.25× relative to LB.

For experiments examining the effects of pH, LB was adjusted to pH 8.5 with sodium hydroxide. To prepare 0.25× LB, standard LB was diluted with sterile water. For the above-mentioned conditions and the effects of various stress conditions, opaque and translucent freezer stocks were inoculated into LB and grown stationary overnight at room temperature to begin each experiment. LB cultures (2 ml) with various stressors were inoculated from the above-mentioned starter cultures and incubated at 37°C with vigorous shaking. Cultures were grown to the desired optical density, serially diluted in LB, and plated on 0.5× LB–0.8% agar. Plates were incubated at 37°C overnight, and CFU per milliliter and number of variant colonies were determined.

Microscopy.

Cells were grown in LB and visualized by phase-contrast microscopy (1,000×) at log phase (optical density at 600 nm [OD600] = 0.2) and early stationary phase (OD600 = 1.1). For samples at log phase, cells were concentrated 10-fold by centrifugation. Images were taken using a Lumenera camera and photographed using the Infinity Analyze software program.

Biofilm analysis.

For biofilm studies, strains to be tested were grown to an A600 of 0.3 in LB and 150 μl was used to inoculate 8 wells of a polystyrene 96-well microtiter plate. Plates were incubated at 37°C for 24 h, and the A600 for each well was determined to measure growth. The medium was removed and replaced with 200 μl of 10% crystal violet solution, and cells were stained for 20 min. Each well was then rinsed 4 times with water and allowed to dry. The crystal violet was solubilized with 300 μl of 33% acetic acid and then diluted with 600 μl of 33% acetic acid. The absorbance of each sample was read at 585 nm. Experiments were repeated in duplicate, with similar results. Biofilm assays in glass tubes were conducted by growing the cells in 2 ml of LB at 37°C for 24 h. At this time medium was removed and replaced with a solution of 10% crystal violet, and staining was carried out for 20 min. Tubes were washed 4 times with 4 ml of sterile water and dried.

Surface motility assays.

Cultures of opaque and translucent variants were grown to stationary phase at 37°C and adjusted to an A600 of 0.7. A 1-μl drop of each colony type was spotted in duplicate on the same 0.3% Eiken agar plate (150-mm plates) and grown for 8 h at 37°C. Motility diameters were measured, and the values of 4 independent measurements for each strain were determined. The differences in motility between opaque and translucent variants had a P value of 0.01 as determined using the Student t test.

Antibiotic susceptibility assays.

Strains to be tested were grown to an OD600 of 0.3 and then diluted to an OD600 of 0.05 with sterile LB. The MICs for various antibiotics were determined using Etest strips on LB agar plates according to the manufacturer's instructions (bioMérieux). The MICs for each antibiotic were determined after 12 h of growth at 37°C. All susceptibility tests were done in duplicate.

Galleria mellonella killing assays.

G. mellonella waxworms were purchased from Wild Bird Goodies Inc., Cumming, GA. A 2-ml culture was inoculated with an opaque or translucent colony and grown shaking at 37°C to an A600 of 0.6. Serial dilutions were prepared in cold LB, and 3 ×104 cells of each colony type were injected into the hemolymph of G. mellonella (200 to 250 mg each). Worms were incubated in a petri plate at 37°C in a humidified incubator. At 24-h intervals, viability was assessed by checking for movement, and worms not exhibiting any movement after prodding with a pipette tip were considered dead and were typically dark brown to black. For all experiments, the serial dilutions used for the inoculations were also plated on 0.8% agar plates to determine overall colony counts of the opaque and translucent cultures and the percent reversion to the other colony type. Only experiments derived with cultures exhibiting less than a 0.5% reversion rate were reported. The reported values represent the averages of 4 independent experiments with at least 10 worms for each strain for each experiment.

RESULTS

Phase-variable control of colony opacity in A. baumannii AB5075.

The highly virulent and multidrug-resistant A. baumannii strain AB5075 (26) was observed to form two distinct colonies on agar plates, termed translucent or opaque (Fig. 1A). There were three requirements to accurately view these colony variants: (i) colonies had to be viewed under a dissecting microscope with oblique indirect illumination, (ii) colonies needed to be at a density greater than approximately 200 per plate, and (iii) 0.5× LB plates with an agar concentration of 0.8% enhanced the colony differences, although they could still be clearly seen on normal (1×) LB–1.5% agar plates if the first two requirements were met. The importance of the indirect illumination is highlighted by the inability to detect colony differences on 0.8% agar plates when visualized under normal room lighting (Fig. 1B). All subsequent experiments in this study were done using 0.5× LB–0.8% agar plates unless indicated otherwise.

FIG 1.

FIG 1

Opaque and translucent colony variants. Panel A shows a representative opaque colony on the left and a translucent colony on the right. In panel B, colonies are viewed under normal room lighting or via oblique lighting from below the colonies. The translucent colony is flanked on either side by two opaque colonies. Panel C shows representative opaque colonies that develop a mottled appearance at 48 h of growth.

When a single pure opaque colony was restreaked, translucent colonies could occasionally be seen. In a similar manner, translucent colonies occasionally gave rise to opaque colonies. Opaque colonies often exhibited obvious translucent sectors or a mottled appearance due to translucent variants arising at high frequency during colony growth (Fig. 1C). However, in the translucent variants, rare opaque sectors were seen, but translucent colonies that exhibited a mottled appearance like the opaque form were never observed. The inability of translucent colonies to produce mottled colonies was not due to the inability to give rise to opaque variants (see below). A single lineage of opaque and translucent variants could be selected by taking a pure opaque colony (designated O1), selecting a translucent variant (T2) from O1, and then selecting an opaque variant (O3) from T2 and then a translucent variant (T4) from O3 so strains O1→T2→O3→T4 were obtained, which were all derived from the same opaque colony.

The above data suggested that the colony opacity phenotype was unstable. To examine this further, the reversion rates of 10 individual opaque or translucent colony variants grown for 16 h were determined by plating dilutions of a resuspended pure colony and examining the resulting colony opacity phenotypes under a dissecting microscope. The rate of reversion from opaque to translucent was highly variable and ranged from 0.09% to 0.85%, with an average reversion rate of 0.29% ± 0.23%, or 1/345 cells. The rate of reversion from translucent to opaque was also highly variable, ranging from 0.05 to 0.45%, with an overall rate of reversion of 0.21% ± 0.16%, or 1/455 cells. However, the differences in reversion rates between opaque and translucent colonies were not statistically significant (P = 0.28).

Phase variation rates increase at high cell density.

The ability of opaque colonies to develop the sectored and/or mottled appearance resulting from translucent variants arising at high frequency during growth required at least 24 h of colony development (Fig. 1C). This suggested that phase variation increased in a density-dependent manner. To examine this possibility, the frequency of phase variation for both opaque and translucent colonies was examined in broth culture at various cell densities (Table 1). The frequency of phase variation in cultures at late log phase (A600 = 0.9) was essentially undetectable (<1/105), However, at an optical density of 1.7, the frequency of phase variation from opaque to translucent cells increased 39-fold above that at an optical density of 0.9 and the frequency of translucent to opaque cells increased 215-fold (Table 1).

TABLE 1.

Effects of growth conditions on phase variation frequency

Phase variationa Growth conditionb Fold increase
O to T High density (A600 = 1.7) 39 ± 16c
T to O High density (A600 = 1.7) 215 + 91c
O to T LB, pH 8.5 2.1 + 1.4d
T to O LB, pH 8.5 1.2 + 1.1d
O to T 0.25× LB 0.4 ± 0.08d
T to O 0.25× LB 0.7 ± 0.07d
O to T Conditioned medium (A. baumannii) 30.4 ± 5.1d
T to O Conditioned medium (A. baumannii) 36.6 ± 20.6d
O to T Conditioned medium (E. coli) 0.9 ± 0.07d
T to O Conditioned medium (E. coli) 1.1 ± 0.2d
O to T LB + 10 μM 3-OH C12-HSL 1.0 ± 0.24d
T to O LB + 10 μM 3-OH C12-HSL 1.7 ± 1.6d
O to T No NaCl 0.53 + 0.22d
T to O No NaCl 0.28 + 0.08d
a

O, opaque; T, translucent.

b

Unless otherwise indicated, all cells under each condition were grown to an A600 of 1.1.

c

Fold increase relative to value for cells at an A600 of 0.9.

d

Fold increase relative to value for cells grown in LB at pH 7.0 and at an A600 of 1.1.

The dependence on high cell density for colony opacity switching could be due to nutrient depletion or increased pH from ammonia generated by the deamination of amino acids present in LB. Therefore, to determine the effects of pH and nutrient depletion, the phase variation frequency was examined at an optical density of 1.1 to determine if these treatments prematurely stimulated phase variation. This optical density was chosen because impact of cell density on stimulating phase variation was found to begin at an optical density of 1.3; therefore, the ability of pH and nutrient depletion to prematurely stimulate phase variation could be determined. When cells were grown in LB at 0.25× (nutrient limited) concentrations, the phase variation frequency was lower than in 1× LB (Table 1). In a similar manner, when cells were grown in broth at pH 8.5, there were no significant changes in the phase variation frequencies relative to pH 7.0 (Table 1).

Phase variation is regulated by the accumulation of an extracellular signal.

The above-described data indicated that the density-dependent increase in phase variation was not due to nutrient depletion or increased pH. In bacteria, cell-to-cell communication is mediated by the secretion of extracellular signals in a process termed quorum sensing (29, 30). This process can regulate activities at high cell density and could be responsible for the increase in phase variation. To assess the role of an extracellular signal, spent culture supernatants were prepared from a culture of an opaque variant at an A600 of 1.6 and the phase variation frequencies of opaque and translucent variants grown to an optical density of 1.1 in this conditioned medium or in LB only were compared. Before use, the pH of conditioned medium was adjusted to 6.5 and nutrients were added back via the addition of a 10× tryptone-yeast extract concentrate to 0.25× the original concentration. The rate of phase variation for both opaque and translucent cells was increased 30- to 35-fold in cells grown in conditioned medium relative to that seen in LB alone (Table 1). This stimulatory activity in conditioned medium was stable to heating at 100°C for 20 min (data not shown). When conditioned medium was prepared from E. coli MG1655 at the same optical density as used for A. baumannii, the rate of phase variation was not significantly increased over the levels seen during growth in LB alone (Table 1). This indicated not that the increase in phase variation with A. baumannii conditioned medium was due to a nonspecific conditioning effect of bacterial growth but that an A. baumannii signal was required. Consistent with this, conditioned medium prepared from a second A. baumannii strain, ATCC 17978, was also capable of activating phase variation in both directions (data not shown).

To determine if the secreted signal was dependent on the abaI autoinducer synthase (31), the phase variation frequency of an abaI mutant was examined. However, there were no significant differences in the phase variation frequency in either direction between opaque and translucent variants in the abaI mutant compared to the wild type (data not shown). In addition, a quorum sensing signal produced in an AbaI-dependent manner is 3-OH C12-homoserine lactone (3-OH C12-HSL) (31, 32). The ability of synthetic 10 μM 3-OH C12-HSL to stimulate phase variation was examined, but no significant differences were observed compared to growth in LB without 3-OH C12-HSL (Table 1).

Effects of stress conditions on phase variation.

To determine if stress influenced the frequency of phase variation, cells were tested in LB under stress conditions similar to those reported by McQueary et al. (33). These conditions include high salt (300 mM NaCl), no salt, H2O2 (50 μM), low iron (100 μM 2,2′-dipyridyl), high iron (100 μM FeCl3), EDTA (100 μM), and ethanol (1%). The frequency of phase variation was decreased in the absence of salt, with the conversion of opaque to translucent decreased 1.9-fold and the conversion of translucent to opaque decreased 3.6-fold compared to values with LB (Table 1). The remaining stress conditions did not significantly alter the switching frequency from opaque to translucent, or from translucent to opaque, relative to that of cells grown in LB only (data not shown). In addition, the opaque and translucent colony morphologies were not altered in the presence of the above-listed stress treatments (data not shown).

Phenotypic differences between opaque and translucent variants. (i) Cell shape.

Cells taken directly from opaque or translucent colonies had essentially indistinguishable morphology when examined under a phase-contrast microscope (data not shown). However, when grown in liquid medium, cells from the opaque and translucent colony variants exhibited significant morphological differences, which became more prominent as cells increased in density and approached stationary phase. In cells at log phase (OD600 = 0.2), both colony variants exhibited the coccobacillus morphology typical of A. baumannii, although cells from the translucent variants were slightly larger (Fig. 2). However, at early stationary phase (OD600 = 1.1), cells from the translucent variant were highly elongated compared to cells from the opaque form, with numerous long rods that were up to 5-fold longer than the opaque cells and occasionally had a bloated appearance (Fig. 2).

FIG 2.

FIG 2

Cell morphology of opaque and translucent variants. All images were captured with an Infinity 2-1 charge-coupled-device (CCD) camera (Lumenera) using an Olympus BX51 phase-contrast microscope at a magnification of ×1,000. Cells were grown in LB and visualized at log phase (OD600 = 0.2) and early stationary phase (OD600 = 1.1).

(ii) Surface motility.

The surface motility of opaque and translucent colony variants was examined on 0.3% Eiken agar plates. The opaque form exhibited a significantly (P = 0.01) increased rate of surface motility (44 ± 3.1 mm) relative to that of the translucent variant (30 ± 4 mm) (Fig. 3A).

FIG 3.

FIG 3

Phenotypic differences between opaque and translucent variants. (A) Surface motility. Opaque or translucent variants were grown in LB to an A600 of 0.6, and a 1-μl drop was then applied to the surface of a 0.3% Eiken agar plate and incubated at 37°C for 7 h before the plate was photographed. Migration distances represent the average of 4 independent assays for each strain, with standard deviations shown. The differences in motility between opaque and translucent variants had a P value of 0.01. (B) Biofilm formation of opaque and translucent variants at 24 h on both polystyrene and glass is shown. For polystyrene, the values are the averages for 8 wells from a representative experiment, and repeated experiments gave similar values. (C) Killing of Galleria mellonella waxworms by opaque and translucent variants at 24 h. The averages from four independent experiments are shown, with at least 11 waxworms used for each strain per experiment. The differences between opaque and translucent variants had a P value of 0.006.

(iii) Biofilm formation.

The ability of opaque and translucent variants to form biofilms was examined on two different abiotic surfaces, polystyrene and glass. After 24 h of growth, cells from the translucent variant were better able to form biofilms on both polystyrene and glass (Fig. 3B). In addition, prolonged incubation of opaque and translucent variants under static conditions in LB resulted in the formation of a prominent cell pellicle in translucent variants that formed across the air-liquid interface (data not shown). This pellicle was absent in the opaque variant.

(iv) Virulence in a Galleria mellonella waxworm model.

To assess if virulence differences were present between the opaque and translucent colony variants, a Galleria mellonella waxworm model was used (34–36). Overall, the opaque variant exhibited a higher rate of killing (85% ± 5%) than the translucent variant (47% ± 10%) (Fig. 3C). Since the translucent form was less virulent, the colony opacity phenotype of cells was determined in worms injected with translucent cells that died between 24 and 48 h. In all cases, bacteria recovered from dead worms exhibited a strong shift from translucent cell populations to the opaque form, with values ranging from 35 to 90% opaque, compared to the less than 0.5% opaque cells in the starting translucent population that was injected into the G. mellonella waxworms.

(v) Antibiotic resistance.

Opaque and translucent variants were tested for resistance against a panel of antibiotics representing different classes (Table 2). There were no significant differences in the levels of resistance to the following antibiotics, with the following MICs (in parentheses) observed for both opaque and translucent variants: tetracycline (2 μg/ml), cefoxitin (96 μg/ml), colistin (3 μg/ml), and rifampin (1.5 μg/ml). For the aminoglycoside class of antibiotics, there were significant differences between opaque and translucent variants for gentamicin (>256 μg/ml for opaque and 32 μg/ml for translucent), amikacin (256 μg/ml for opaque and 128 μg/ml for translucent), and tobramycin (48 μg/ml for opaque and 16 μg/ml for translucent). The levels of resistance for trimethoprim, ciprofloxacin, and ceftriaxone could not be determined, as the levels of resistance for AB5075 were above the highest concentration of antibiotic present in the Etest strips.

TABLE 2.

Antibiotic resistances of opaque and translucent variants

Antibiotic MIC (μg/ml) for variants
Opaque Translucent
Tetracycline 2 2
Cefoxitin 96 96
Colistin 3 3
Rifampin 1.5 1.5
Gentamicin >256 32
Amikacin 256 128
Tobramycin 48 16
Trimethoprim NDa ND
Ciprofloxacin ND ND
Ceftriaxone ND ND
a

ND, not determined, as the MIC for each strain was above the level in the Etest strips.

Additional strains of A. baumannii exhibit the opaque/translucent colony phenotype.

To determine if the variable colony phenotype was limited to A. baumannii strain AB5075, the ability of additional strains of A. baumannii to form colony variants was investigated. Four additional isolates, ATCC 17978, AB1712, AB307-0294, and AB0057, were tested for differences in colony morphology; AB1712, AB307-0294, and AB0057 produced opaque and translucent colony variants. The rate of phase variation for AB0057 and AB307-0294 ranged from 1/102 to 1/103 for both opaque and translucent variants. However, the rate of phase variation for AB1712 was greatly favored in the translucent to opaque direction (1/102) compared to the opaque to translucent direction (ranging from 1/104 to 1/105). We were unable to detect variants of ATCC 17978, and the colony morphology of this strain was distinct from that of most other A. baumannii isolates and exhibited a translucent phenotype with irregular and spreading (motile) colonies on 0.8% agar plates. The inability of ATCC 17978 to undergo phase variation was not due to decreased production of the extracellular signal that stimulates phase variation, as spent culture supernatants of ATCC 17978 promoted switching of both opaque and translucent variants of AB5075 (data not shown).

Since the opaque form was more virulent in Galleria mellonella, it was of interest to determine if the opaque form also predominated in vivo during human infections. Fresh clinical isolates that were passaged only once after the primary isolation from body sites were tested for the ability to produce opaque or translucent colonies. Among the isolates, 7 were predominately opaque (AB991, AB1009, AB1011, AB1020, AB499, AB552, and AB1051) and 5 were translucent (AB997, AB732, AB248, AB45, and AB1040). The opaque isolates AB991, AB1009, AB1011, and AB1020 were capable of phase variation at frequencies of 1/102 to 1/103 for both the opaque and translucent forms. Isolates AB1040, AB1051, and AB499 were capable of phase variation at significantly lower frequencies (approximately1/105). Lastly, the translucent clinical isolates AB997, AB732, AB248, and AB45 did not switch to the opaque form at detectable frequencies (<1/105).

DISCUSSION

This article reports on a phase-variable property in A. baumannii strain AB5075 involved in multiple phenotypes, including colony opacity, cell shape, surface motility, biofilm formation, antibiotic resistance, and virulence. To our knowledge, this represents the first reported example of phase variation in A. baumannii. Currently, the mechanism responsible for this phase variation is unknown, and whole-genome sequencing of opaque and translucent variants is under way to determine if nucleotide changes are responsible. Alternatively, the phase variation switch may involve a bistable switch or nonmutational epigenetic changes that influence the state of methylation at a regulatory region, similar to the regulatory mechanism for type I pilus and antigen 43 expression in Escherichia coli and capsule variation Streptococcus pneumoniae (16, 22–24, 37). The fact that this phase variation is regulated by high density suggests that a mechanism like slipped-strand mispairing is unlikely, as this should occur independently of cell density. Regardless of the mechanism, the pleiotropic effects associated with the switch between opaque and translucent variants suggest that the activity of a global regulator, which controls multiple genes, is directly impacted by the phase variation and undergoes an on and off switch.

The ability of A. baumannii to undergo phase variation is stimulated at high cell density and by spent culture supernatants from high-density cultures. This result suggests that an extracellular signal may accumulate and activate a regulatory pathway for phase variation. The nature of this signal is unknown, but it is not 3-OH C12-HSL (Table 1). The components of the signaling pathway that control phase variation are likely to be complex. In an effort to begin understanding this pathway, transposon mutagenesis has been used to identify mutants that either are blocked in phase variation or undergo phase variation at greatly increased frequencies over that of the wild type. The characterization of these mutants will help reveal the regulatory network(s) and possible mechanism(s) that control this process.

The ability of A. baumannii to rapidly shift between opaque and translucent variants is likely important for A. baumannii to adapt to different environments. For example, in the opaque form, cells have enhanced virulence in Galleria mellonella and increased surface motility but are less able to form biofilms. This may provide an advantage in vivo and aid in the dissemination of bacteria in the host. In contrast, the translucent form exhibits reduced virulence and motility but is better able to form biofilms on abiotic surfaces. This may facilitate the colonization of various environments outside a host. The rapid shift between opaque and translucent variants would allow for flexibility in adapting to different environments and ensure that a subpopulation of cells are always present that are best suited to a particular environment. It is also possible that the opaque and translucent variants confer advantages at different tissue sites in vivo. A. baumannii isolates taken from human infections were found in either the opaque or translucent form. The opaque form with increased virulence and motility may be associated with acute infection. In contrast, the translucent form may be associated with chronic infections due to its enhanced biofilm forming ability.

Several aspects of the colony opacity phenotype remain unknown. First, why do opaque colonies look different from translucent colonies? These differences could be due to variation in surface polysaccharides, outer membrane proteins, or general cell envelope changes. Opaque variants appear slightly more mucoid when plates are left for several days at room temperature, suggesting differences in surface polysaccharides. The differences in aminoglycoside resistance between opaque and translucent variants also suggest cell envelope changes, although these changes are unlikely to alter surface charge, as the levels of resistance to another cationic antibiotic, colistin, are unchanged between opaque and translucent variants. A second unknown aspect of the opaque/translucent phenotype is why translucent colonies appear opaque when they are at low colony density. As translucent colonies become more crowded, they acquire the translucent appearance and are then easily distinguished from opaque variants. Interestingly, if translucent variants are grown near a line of pregrown A. baumannii cells, they appear translucent at low density, indicating that some aspect of growth near other cells is required for the translucent phenotype (data not shown). This could be due to secretion of an extracellular signal that facilitates the translucent morphology, or it could be due to pH changes or nutrient depletion. The mechanism for this is currently being examined.

The ability of other A. baumannii clinical isolates to switch between opaque and translucent variants was examined, and it was revealed that this was a common but not universal phenotype. The frequency of phase variation between strains differed significantly, and in some cases, the colony phase variation was greatly favored in one direction, translucent to opaque. We were unable to detect colony variants in the commonly used strain ATCC 17978; however, this strain was able to produce the extracellular factor that stimulated phase variation. It is possible that ATCC 17978 is unable to undergo phase variation at detectable frequencies. Another possibility is that the opaque and translucent phenotype differences in this strain are too subtle to detect. In general, colonies of ATCC 17978 were very different from the other A. baumannii strains examined and consisted of irregular translucent colonies that partially spread across the surface of 0.8% agar plates

This colony variation and the associated phenotypes are significant for A. baumannii researchers. First, since the colony opacity differences are difficult, if not impossible, to determine under normal room lighting, laboratories working with the same strain may unknowingly be working with different colony variants. Second, this may also be problematic within the same laboratory, where different variants may unknowingly be used at different times. In fact, after observing this colony phase variation, we checked our laboratory stocks of various A. baumannii strains, and in most cases, they contained a mixture of opaque and translucent variants. This was also true of A. baumannii strains that were obtained from other laboratories. Recently, a large-scale transposon insertion library was generated in AB5075 (38). Various mutants obtained from this library frequently contained both opaque and translucent variants, and in some cases, a third variant was observed that formed small grayish colonies under oblique lighting. We have also occasionally noticed these small gray variants in our laboratory but have not characterized them further. In summary, we would caution all A. baumannii investigators to carefully examine their laboratory stocks for these colony variants and choose a single variant for all studies involving mutant phenotypes.

ACKNOWLEDGMENTS

We are grateful to Charles Moran and William Shafer for critical reading of the manuscript. In addition, we thank Robert Bonomo, Colin Manoil, Anthony Campagnari, and Sarah Satola for the gift of various A. baumannii strains.

This work was funded by grant 1R21AI115183 from the National Institutes of Health and by funds from the Atlanta Research and Education Foundation. P.N.R. is also supported by grants from the Merit Review program and a Research Career Scientist Award, both from the Department of Veterans Affairs.

REFERENCES

  • 1.Nemec A, Krizova L, Maixnerova M, van der Reijden T, Deschaght P, Passet V, Vaneechoutte M, Brisse S, Dijkshoorn L. 2011. Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Res Microbiol 162:393–404. doi: 10.1016/j.resmic.2011.02.006. [DOI] [PubMed] [Google Scholar]
  • 2.Bergogne-Bérézin E, Towner KJ. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features. Clin Microbiol Rev 9:148–165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Gootz TD, Marra A. 2008. Acinetobacter baumannii: an emerging multidrug-resistant threat. Exp Rev Anti Infect Ther 6:309–325. doi: 10.1586/14787210.6.3.309. [DOI] [PubMed] [Google Scholar]
  • 4.Joly-Guillou ML. 2005. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect 11:868–873. http://dx.doi.org/10.1111/j.1469-0691.2005.01227.x. [DOI] [PubMed] [Google Scholar]
  • 5.Peleg AY, Seifert H, Patterson DL. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21:538–582. doi: 10.1128/CMR.00058-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Scott PT, Petersen K, Fishbain J. 2004. Acinetobacter baumannii infections among patients at military medical facilities treating injured U.S. service members, 2002–2004. MMWR Morb Mortal Wkly Rep 53:1063–1066. [PubMed] [Google Scholar]
  • 7.Aronson NE, Sanders JW, Moran KA. 2006. In harm's way: infections in deployed American military forces. Clin Infect Dis 43:1045–1051. doi: 10.1086/507539. [DOI] [PubMed] [Google Scholar]
  • 8.Sebeny PJ, Riddle MS, Petersen K. 2008. Acinetobacter baumannii skin and soft tissue infection associated with war trauma. Clin Infect Dis 47:444–449. doi: 10.1086/590568. [DOI] [PubMed] [Google Scholar]
  • 9.Murray CK, Wilkins K, Molter NC, Li F, Yu Y, Sprott MA, Eastridge B, Blackbourne LH, Hospenthal DR. 2011. Infections complicating the care of combat casualties during operations Iraqi Freedom and Enduring Freedom. J Trauma 71(1 Suppl):S62–S73. doi: 10.1097/TA.0b013e3182218c99. [DOI] [PubMed] [Google Scholar]
  • 10.Murray CK, Hospenthal DR. 2005. Treatment of multidrug resistant Acinetobacter. Curr Opin Infect Dis 18:502–506. doi: 10.1097/01.qco.0000185985.64759.41. [DOI] [PubMed] [Google Scholar]
  • 11.Hujer KM, Hujer AM, Hulten EA, Bajaksouzian S, Adams JM, Donskey CJ, Ecker DJ, Massire C, Eshoo MW, Sampath R, Thomson JM, Rather PN, Craft DW, Fishbain JT, Ewell AJ, Jacobs MR, Paterson DL, Bonomo RA. 2006. Analysis of antibiotic resistance genes in multidrug-resistant Acinetobacter sp. isolates from military and civilian patients treated at the Walter Reed Army Medical Center. Antimicrob Agents Chemother 50:4114–4123. doi: 10.1128/AAC.00778-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Rice LB. 2006. Challenges in identifying new antimicrobial agents effective for treating infections with Acinetobacter baumannii and Pseudomonas aeruginosa. Clin Infect Dis 43(Suppl 2):S100–S105. doi: 10.1086/504487. [DOI] [PubMed] [Google Scholar]
  • 13.Perez F, Hujer AM, Hujer K, Decker BK, Rather PN, Bonomo RA. 2007. The challenge of multidrug antibiotic resistance in Acinetobacter baumannii. Antimicrob Agents Chemother 51:3471–3484. doi: 10.1128/AAC.01464-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Dijkshoorn L, Nemec A, Seifert H. 2007. An increasing threat in hospitals: multidrug resistant Acinetobacter baumannii. Nat Rev Microbiol 5:939–951. doi: 10.1038/nrmicro1789. [DOI] [PubMed] [Google Scholar]
  • 15.Queenan AM, Pillar CM, Deane J, Sahm DF, Lynch AS, Flamm RK, Peterson J, Davies TA. 2012. Multidrug resistance among Acinetobacter spp. in the US and activity profile of key agents: results from CAPITAL surveillance 2010. Diagn Microbiol Infect Dis 73:267–270. doi: 10.1016/j.diagmicrobio.2012.04.002. [DOI] [PubMed] [Google Scholar]
  • 16.Henderson IR, Owen P, Nataro JP. 1999. Molecular switches—the ON and OFF of bacterial phase variation. Mol Microbiol 33:919–932. doi: 10.1046/j.1365-2958.1999.01555.x. [DOI] [PubMed] [Google Scholar]
  • 17.Deitsch KW, Lukehart SA, Stringer JR. 2009. Common strategies for antigenic variation by bacterial fungal and protozoan pathogens. Nat Rev Microbiol 7:493–503. doi: 10.1038/nrmicro2145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Swanson J. 1978. Studies on gonococcus infection. XIV. Colony color and opacity colony variants of Neisseria gonorrhoeae. Infect Immun 19:320–331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Stern A, Brown M, Nickel P, Meyer TF. 1986. Opacity genes in Neisseria gonorrhoeae: control of phase and antigenic variation. Cell 47:61–71. doi: 10.1016/0092-8674(86)90366-1. [DOI] [PubMed] [Google Scholar]
  • 20.Weiser JN, Austrian R, Sreenivavas PK, Masure HR. 1994. Phase variation in pneumococcal opacity: relationship between colonial morphology and nasopharyngeal colonization. Infect Immun 62:2582–2589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.McCarter LL. 1998. OpaR, a homolog of Vibrio harveyi LuxR controls opacity in Vibrio parahaemolyticus. J Bacteriol 180:3166–3173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Manso AS, Chai MH, Atack JM, Furi L, De Ste Croix M, Haigh R, Trappetti C, Ogunniyi AD, Shewell LK, Boitano M, Clark TA, Korlach J, Blades M, Mirkes E, Gorban AN, Paton JC, Jennings MP, Oggioni MR. 2014. A random six-phase switch regulates pneumococcal virulence via global epigenetic changes. Nat Commun 5:5055. doi: 10.1038/ncomms6055. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.van der Woude M, Braaten B, Low D. 1996. Epigenetic phase variation of the pap operon in Escherichia coli. Trends Microbiol 4:5–9. doi: 10.1016/0966-842X(96)81498-3. [DOI] [PubMed] [Google Scholar]
  • 24.Henderson IR, Meehan M, Owen P. 1997. A novel regulatory mechanism for a novel phase-variable outer membrane protein of Escherichia coli. Adv Exp Med Biol 412:349–355. [DOI] [PubMed] [Google Scholar]
  • 25.Davidsen T, Tonjum T. 2006. Meningococcal genome dynamics. Nat Rev Microbiol 4:11–22. doi: 10.1038/nrmicro1324. [DOI] [PubMed] [Google Scholar]
  • 26.Jacobs AC, Thompson MG, Black CC, Kessler JL, Clark LP, McQueary CN, Gancz HY, Corey BW, Moon JK, Si Y, Owen MT, Hallock JD, Kwak YI, Summers A, Li CZ, Rasko DA, Penwell WF, Honnold CL, Wise MC, Waterman PE, Lesho EP, Stewart RL, Actis LA, Palys TJ, Craft DW, Zurawski DV. 2014. AB5075, a highly virulent isolate of Acinetobacter baumannii, as a model strain for the evaluation of pathogenesis and antimicrobial treatments. mBio 5(3):e01076-14. doi: 10.1128/mBio.01076-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Adams MA, Goglin K, Molyneaux N, Hujer KM, Lavender H, Jamison JJ, MacDonald IJ, Martin KM, Russo T, Campagnari AA, Hujer AM, Bonomo RA. 2008. Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii. J Bacteriol 190:8053–8064. doi: 10.1128/JB.00834-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Smith MG, Gianoulis TA, Pukatzki S, Mekalanos JJ, Ornston LN, Gerstein M, Snyder M. 2007. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev 21:601–614. doi: 10.1101/gad.1510307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Miller MB, Bassler BL. 2001. Quorum sensing in bacteria. Annu Rev Microbiol 55:165–199. doi: 10.1146/annurev.micro.55.1.165. [DOI] [PubMed] [Google Scholar]
  • 30.Fuqua C, Winans SC, Greenberg EP. 1996. Census and consensus in bacterial ecosystems: the LuxR-LuxI family of quorum sensing transcriptional regulators. Annu Rev Microbiol 50:727–751. [DOI] [PubMed] [Google Scholar]
  • 31.Niu C, Clemmer KM, Bonomo RA, Rather PN. 2008. Isolation and characterization of an autoinducer synthase from Acinetobacter baumannii. J Bacteriol 190:3386–3392. doi: 10.1128/JB.01929-07. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Stacy DM, Welch MA, Rather PN, Blackwell HE. 2012. Attenuation of quorum sensing in the pathogen Acinetobacter baumannii using non-native N-acyl homoserine lactones. ACS Chem Biol 19:1719–1728. doi: 10.1021/cb300351x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.McQueary CN, Kirkup BC, Si Y, Barlow M, Actis LA, Craft DW, Zurawski DV. 2012. Extracellular stress and lipopolysaccharide modulate Acinetobacter baumannii surface associated motility. J Microbiol 50:434–443. doi: 10.1007/s12275-012-1555-1. [DOI] [PubMed] [Google Scholar]
  • 34.Peleg AY, Jara S, Monga D, Eliopoulos GM, Moellering RC Jr, Mylonakis E. 2009. Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics. Antimicrob Agents Chemother 53:2605–2609. doi: 10.1128/AAC.01533-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Gaddy JA, Arivett BA, McConnell MJ, Lopez-Rojas R, Actis LA. 2012. Role of acetobactin mediated iron acquisition functions in the interaction of Acinetobacter baumannii strain ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars, and mice. Infect Immun 80:1015–1024. doi: 10.1128/IAI.06279-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Ramarao N, Nielsen-Leroux C, Lereclus D. 2012. The insect Galleria mellonella as a powerful infection model to investigate bacterial pathogenesis. J Vis Exp 11(70):e4392. doi: 10.3791/4392. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Dubnau D, Losick R. 2006. Bistability in bacteria. Mol Microbiol 61:564–572. doi: 10.1111/j.1365-2958.2006.05249.x. [DOI] [PubMed] [Google Scholar]
  • 38.Gallagher LA, Ramage E, Weiss EJ, Radey M, Hayden HS, Held KG, Huse HK, Zurawski DV, Brittnacher MJ, Manoil C. 6 April 2015. Resources for genetic and genomic analysis of the emerging pathogen Acinetobacter baumannii. J Bacteriol doi: 10.1128/JB.00131-15. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Bacteriology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES